share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NORA JOHNSON SUZANNE M

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NORA JOHNSON SUZANNE M

輝瑞 | 4:持股變動聲明-董事 NORA JOHNSON SUZANNE M
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心訊息
Suzanne M. Nora Johnson, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The action type and status, as well as the number of shares held after the action, are also not provided in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Suzanne M. Nora Johnson, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The action type and status, as well as the number of shares held after the action, are also not provided in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
輝瑞公司 [PFE] 的舉報人蘇珊娜·諾拉·約翰遜於2024年4月25日參與了一筆交易。有關交易性質的具體細節,包括股票數量、交易價格和總價值,尚未披露。公告中也未提供行動類型和狀態以及行動後持有的股票數量。建議投資者尋求更多信息,以充分了解這一事件對其投資決策的影響。
輝瑞公司 [PFE] 的舉報人蘇珊娜·諾拉·約翰遜於2024年4月25日參與了一筆交易。有關交易性質的具體細節,包括股票數量、交易價格和總價值,尚未披露。公告中也未提供行動類型和狀態以及行動後持有的股票數量。建議投資者尋求更多信息,以充分了解這一事件對其投資決策的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息